Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Presynaptic mechanisms controlling acetylcholine release refer to the integrated physiological processes within the cholinergic nerve terminal that regulate the synthesis, packaging, and exocytosis of acetylcholine (ACh). This pathway begins with the uptake of choline via the high-affinity choline transporter (CHT1) and its subsequent acetylation by choline acetyltransferase (ChAT) (Source: UniProt P28329, P04812). Synthesized ACh is then sequestered into synaptic vesicles by the vesicular acetylcholine transporter (VAChT) (Source: UniProt Q16572). Upon neuronal depolarization, voltage-gated calcium channels (typically P/Q-type) open, triggering the SNARE-mediated fusion of vesicles with the presynaptic membrane to release ACh into the synaptic cleft (Source: PubMed PMID: 15740610). This release is modulated by presynaptic autoreceptors, primarily M2 and M4 muscarinic receptors, which provide inhibitory feedback (Source: StatPearls, Cholinergic Receptors). Dysregulation of these mechanisms is implicated in neurodegenerative diseases like Alzheimer's and neuromuscular disorders such as Lambert-Eaton myasthenic syndrome, making these presynaptic components vital therapeutic targets (Source: PubMed PMID: 21496427).
Modulation of acetylcholine release through inhibition of SNARE-mediated exocytosis, blockade of high-affinity choline uptake, inhibition of vesicular transport, or modulation of presynaptic auto- and heteroreceptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic mechanisms controlling acetylcholine release.